chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Hyperhidrosis, Pain in extremity, Sleep disorder
Clinical narrative: headache; sweating; couldn't sleep; felt so miserable all night with her shoulder; sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 31-Mar-2021 and was forwarded to Moderna on 31-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (sweating), SLEEP DISORDER (couldn't sleep) and ARTHRALGIA (felt so miserable all night with her shoulder) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 30-Mar-2021, the patient experienced HEADACHE (headache), HYPERHIDROSIS (sweating), SLEEP DISORDER (couldn't sleep) and ARTHRALGIA (felt so miserable all night with her shoulder). The patient was treated with PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (TYLENOL SINUS MEDICATION) for Adverse event, at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN EXTRA STRENGTH) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (sweating), SLEEP DISORDER (couldn't sleep) and ARTHRALGIA (felt so miserable all night with her shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Salivary hypersecretion, Secretion discharge
Clinical narrative: spitting out of her mouth,lot of saliva came out of her mouth; mucus came out of her mouth; This spontaneous case was reported by a consumer and describes the occurrence of SALIVARY HYPERSECRETION (spitting out of her mouth,lot of saliva came out of her mouth) and SECRETION DISCHARGE (mucus came out of her mouth) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for an unknown indication.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced SALIVARY HYPERSECRETION (spitting out of her mouth,lot of saliva came out of her mouth) and SECRETION DISCHARGE (mucus came out of her mouth). At the time of the report, SALIVARY HYPERSECRETION (spitting out of her mouth,lot of saliva came out of her mouth) and SECRETION DISCHARGE (mucus came out of her mouth) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Vaccination site discomfort, Vaccination site erythema, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Usual discomfort at injection site), RASH PRURITIC (Itchy rash on left arm), RASH ERYTHEMATOUS ((Itchy) red rash on left arm), VACCINATION SITE RASH (Rash at the site of the injection in left arm) and VACCINATION SITE PAIN (soreness at the site of the injection in left arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Medical history was not provided by the reporter.  Concomitant products included AMLODIPINE, LOSARTAN, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, ACYCLOVIR [ACICLOVIR], SALBUTAMOL (VENTOLIN [SALBUTAMOL]) and AZELASTINE HYDROCHLORIDE (ASTELIN [AZELASTINE HYDROCHLORIDE]) for an unknown indication. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at the site of the injection in left arm), VACCINATION SITE PAIN (soreness at the site of the injection in left arm), VACCINATION SITE PRURITUS (itching at the site of the injection in left arm) and VACCINATION SITE ERYTHEMA (redness at the site of the injection in left arm). On 23-Feb-2021, the patient experienced VACCINATION SITE DISCOMFORT (Usual discomfort at injection site), RASH PRURITIC (Itchy rash on left arm) and RASH ERYTHEMATOUS ((Itchy) red rash on left arm). In February 2021, VACCINATION SITE RASH (Rash at the site of the injection in left arm), VACCINATION SITE PAIN (soreness at the site of the injection in left arm), VACCINATION SITE PRURITUS (itching at the site of the injection in left arm) and VACCINATION SITE ERYTHEMA (redness at the site of the injection in left arm) had resolved. At the time of the report, VACCINATION SITE DISCOMFORT (Usual discomfort at injection site), RASH PRURITIC (Itchy rash on left arm) and RASH ERYTHEMATOUS ((Itchy) red rash on left arm) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Treatment medications were not used by the patient. This case was linked to MOD-2021-244825. Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Additional events: Vaccination site discomfort, Rash pruritic, Rash erythematous.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Usual discomfort at injection site), RASH PRURITIC (Itchy rash on left arm), RASH ERYTHEMATOUS ((Itchy) red rash on left arm), VACCINATION SITE RASH (Rash at the site of the injection in left arm) and VACCINATION SITE PAIN (soreness at the site of the injection in left arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Medical history was not provided by the reporter.  Concomitant products included AMLODIPINE, LOSARTAN, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, ACYCLOVIR [ACICLOVIR], SALBUTAMOL (VENTOLIN [SALBUTAMOL]) and AZELASTINE HYDROCHLORIDE (ASTELIN [AZELASTINE HYDROCHLORIDE]) for an unknown indication. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at the site of the injection in left arm), VACCINATION SITE PAIN (soreness at the site of the injection in left arm), VACCINATION SITE PRURITUS (itching at the site of the injection in left arm) and VACCINATION SITE ERYTHEMA (redness at the site of the injection in left arm). On 23-Feb-2021, the patient experienced VACCINATION SITE DISCOMFORT (Usual discomfort at injection site), RASH PRURITIC (Itchy rash on left arm) and RASH ERYTHEMATOUS ((Itchy) red rash on left arm). In February 2021, VACCINATION SITE RASH (Rash at the site of the injection in left arm), VACCINATION SITE PAIN (soreness at the site of the injection in left arm), VACCINATION SITE PRURITUS (itching at the site of the injection in left arm) and VACCINATION SITE ERYTHEMA (redness at the site of the injection in left arm) had resolved. At the time of the report, VACCINATION SITE DISCOMFORT (Usual discomfort at injection site), RASH PRURITIC (Itchy rash on left arm) and RASH ERYTHEMATOUS ((Itchy) red rash on left arm) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Treatment medications were not used by the patient. This case was linked to MOD-2021-244825. Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Additional events: Vaccination site discomfort, Rash pruritic, Rash erythematous.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Limb discomfort, Pain
Clinical narrative: legs were exhausted; not much pain just a little; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (legs were exhausted), PAIN (not much pain just a little) and FATIGUE (fatigue) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001821A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (legs were exhausted), PAIN (not much pain just a little) and FATIGUE (fatigue). At the time of the report, LIMB DISCOMFORT (legs were exhausted), PAIN (not much pain just a little) and FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No Treatment details were provided.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Genital rash, Insomnia, Pruritus, Rash, Vaccination site discolouration
Clinical narrative: Genital rash; rash severity increases at night to the point that he cannot sleep; When pressed on the bump, it turns yellow; rash on legs/Hand rash/rash become very bumpy if patient itches; Itching; This spontaneous case was reported by a pharmacist and describes the occurrence of PRURITUS (Itching), GENITAL RASH (Genital rash), INSOMNIA (rash severity increases at night to the point that he cannot sleep), VACCINATION SITE DISCOLOURATION (When pressed on the bump, it turns yellow) and RASH (rash on legs/Hand rash/rash become very bumpy if patient itches) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PRURITUS (Itching). On 25-Mar-2021, the patient experienced RASH (rash on legs/Hand rash/rash become very bumpy if patient itches). On an unknown date, the patient experienced GENITAL RASH (Genital rash), INSOMNIA (rash severity increases at night to the point that he cannot sleep) and VACCINATION SITE DISCOLOURATION (When pressed on the bump, it turns yellow). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 50 mg once a day; PREDNISONE at a dose of 50 mg once a day and CETIRIZINE HYDROCHLORIDE (CETRIZINE) at a dose of 20 mg once a day. At the time of the report, PRURITUS (Itching), GENITAL RASH (Genital rash), INSOMNIA (rash severity increases at night to the point that he cannot sleep), VACCINATION SITE DISCOLOURATION (When pressed on the bump, it turns yellow) and RASH (rash on legs/Hand rash/rash become very bumpy if patient itches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Apr-2021: This follow up was received on 02 April 2021, which reported that the rash developed did not subside and so the patient wants to know if it is okay to receive second dose which was due by 10 days. On 23-Jun-2021: Received second dose of vaccination which didn't seem like aggravating the issue-Updated treatment medications.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Body temperature, Chills, Headache, Pyrexia
Clinical narrative: horrible headaches; crazy dreams; chills; fever, under 101; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (horrible headaches), ABNORMAL DREAMS (crazy dreams), CHILLS (chills) and PYREXIA (fever, under 101) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced HEADACHE (horrible headaches), ABNORMAL DREAMS (crazy dreams), CHILLS (chills) and PYREXIA (fever, under 101). On 31-Mar-2021, HEADACHE (horrible headaches), ABNORMAL DREAMS (crazy dreams), CHILLS (chills) and PYREXIA (fever, under 101) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Skin discolouration
Clinical narrative: big red patch; hot; itchy; red patch; turning a dark shade; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), ERYTHEMA (red patch), SKIN DISCOLOURATION (turning a dark shade), FEELING HOT (hot) and ERYTHEMA (big red patch) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced SKIN DISCOLOURATION (turning a dark shade). On 28-Mar-2021, the patient experienced PRURITUS (itchy), ERYTHEMA (red patch) and FEELING HOT (hot). On 30-Mar-2021, the patient experienced ERYTHEMA (big red patch). At the time of the report, PRURITUS (itchy), ERYTHEMA (red patch), SKIN DISCOLOURATION (turning a dark shade), FEELING HOT (hot) and ERYTHEMA (big red patch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported. Allergy medication were used as concomitant medication.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Vaccination site pain
Clinical narrative: Feels like I got hit with a baseball bat; pain in toes; Vaccination site pain; sore throughout body; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore throughout body), PAIN (general body pain), PAIN IN EXTREMITY (pain in toes) and VACCINATION SITE PAIN (Vaccination site pain) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included Lyme disease since an unknown date and Leukopenia. Concomitant products included LEVOTHYROXINE, CETIRIZINE and VITAMINS NOS for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN (sore throughout body), PAIN IN EXTREMITY (pain in toes) and VACCINATION SITE PAIN (Vaccination site pain). On an unknown date, the patient experienced PAIN (general body pain). At the time of the report, PAIN (sore throughout body), PAIN (general body pain), PAIN IN EXTREMITY (pain in toes) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Myalgia
Clinical narrative: on the second day after vaccine patient had a headache for the day; fatigue; muscle pain; chills; fever of 101.1 degrees F; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), PYREXIA (fever of 101.1 degrees F) and HEADACHE (on the second day after vaccine patient had a headache for the day) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021A) for COVID-19 vaccination.     Concomitant products included METOPROLOL, DULOXETINE and OLANZAPINE for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 20-Mar-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (fever of 101.1 degrees F). On 21-Mar-2021, the patient experienced HEADACHE (on the second day after vaccine patient had a headache for the day). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 21-Mar-2021, FATIGUE (fatigue) and HEADACHE (on the second day after vaccine patient had a headache for the day) had resolved. On 22-Mar-2021, MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (fever of 101.1 degrees F) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Body temperature: elevated (High) 101.1.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient has scheduled 2nd dose of vaccine on17-04-2021.  Patient reports taking an over the counter Migraine Pill (NOS) that contained caffeine.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: on the second day after vaccine patient had a headache for the day; fatigue; muscle pain; chills; fever of 101.1 degrees F; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), PYREXIA (fever of 101.1 degrees F) and HEADACHE (on the second day after vaccine patient had a headache for the day) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021A) for COVID-19 vaccination.     Concomitant products included METOPROLOL, DULOXETINE and OLANZAPINE for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 20-Mar-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (fever of 101.1 degrees F). On 21-Mar-2021, the patient experienced HEADACHE (on the second day after vaccine patient had a headache for the day). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 21-Mar-2021, FATIGUE (fatigue) and HEADACHE (on the second day after vaccine patient had a headache for the day) had resolved. On 22-Mar-2021, MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (fever of 101.1 degrees F) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Body temperature: elevated (High) 101.1.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient has scheduled 2nd dose of vaccine on17-04-2021.  Patient reports taking an over the counter Migraine Pill (NOS) that contained caffeine.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: between 9:30am and 11am she had excessive discharge/noticed the presence of both blood clots and bright red blood; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of HEAVY MENSTRUAL BLEEDING (between 9:30am and 11am she had excessive discharge/noticed the presence of both blood clots and bright red blood) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (between 9:30am and 11am she had excessive discharge/noticed the presence of both blood clots and bright red blood). At the time of the report, HEAVY MENSTRUAL BLEEDING (between 9:30am and 11am she had excessive discharge/noticed the presence of both blood clots and bright red blood) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included 1 iron pill
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Depression, Inappropriate schedule of product administration
Clinical narrative: Missed his second appointment; Anxiety; Depression; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed his second appointment), ANXIETY (Anxiety) and DEPRESSION (Depression) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Mental distress (Patient had anxiety and depression for many years.).    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed his second appointment), ANXIETY (Anxiety) and DEPRESSION (Depression). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed his second appointment) had resolved and ANXIETY (Anxiety) and DEPRESSION (Depression) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported. Treatment not provided.     Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up received on 15-02-2021 included no new information.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Hyperlipidemia.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were  included high blood pressure medication and cholesterol medication. Treatment medication was unknown   Reporter did not allow further contact
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 57 days since first dose on 2Feb2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days since first dose on 2Feb2021) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012MZ0A) for COVID-19 vaccination.     Concurrent medical conditions included COPD (COPD), Asthma (Asthma) and Emphysema (Emphysema). Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), SERTRALINE HYDROCHLORIDE (ZOLOFT), ARIPIPRAZOLE (ABILIFY), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), ATORVASTATIN CALCIUM (LIPITOR) and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days since first dose on 2Feb2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days since first dose on 2Feb2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medications were included inhalers and vitamins No Treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: TCR: Dose 2 vaccine received by the patient.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness
Clinical narrative: Very Sick; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very Sick) and CHILLS (Chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced ILLNESS (Very Sick) and CHILLS (Chills). At the time of the report, ILLNESS (Very Sick) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medications were unknown
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Tachycardia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Terrible fatigue) and TACHYCARDIA (rapid heart beat up to 128BPM) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced FATIGUE (Terrible fatigue). On 03-Mar-2021, the patient experienced TACHYCARDIA (rapid heart beat up to 128BPM). At the time of the report, FATIGUE (Terrible fatigue) and TACHYCARDIA (rapid heart beat up to 128BPM) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medications were provided. No treatment details were provided. Reporter did not allow further contact.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Vaccination site pain
Clinical narrative: pain in arm; still having trouble raising her left arm/couldn't life her arm; couldn't life her arm to do anything; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), INJECTED LIMB MOBILITY DECREASED (still having trouble raising her left arm/couldn't life her arm) and INJECTED LIMB MOBILITY DECREASED (couldn't life her arm to do anything) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE and Wellbutrin XR for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), INJECTED LIMB MOBILITY DECREASED (still having trouble raising her left arm/couldn't life her arm) and INJECTED LIMB MOBILITY DECREASED (couldn't life her arm to do anything). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in arm), INJECTED LIMB MOBILITY DECREASED (still having trouble raising her left arm/couldn't life her arm) and INJECTED LIMB MOBILITY DECREASED (couldn't life her arm to do anything) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       She states she is concerned about getting the second dose of the vaccine because she heard the second dose is even worse than the first and is afraid, she will not be able to use her arm at all
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Mobility decreased, Nasal congestion
Clinical narrative: COVID-19; congestion; sore throat; heart palpitation; could barely move the arm of injection; aches; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), PALPITATIONS (heart palpitation) and MOBILITY DECREASED (could barely move the arm of injection) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVETIRACETAM (KEPPRA) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), PALPITATIONS (heart palpitation), MOBILITY DECREASED (could barely move the arm of injection), PAIN (aches), CHILLS (chills) and FATIGUE (fatigue). On 26-Mar-2021, the patient experienced COVID-19 (COVID-19). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of UNK dosage form. At the time of the report, COVID-19 (COVID-19), NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), PALPITATIONS (heart palpitation), MOBILITY DECREASED (could barely move the arm of injection), PAIN (aches), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medications were depression medicine and migraine medicine. Other treatment medications taken were  inhaler and a medicine for cough.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Palpitations
Clinical narrative: COVID-19; congestion; sore throat; heart palpitation; could barely move the arm of injection; aches; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), PALPITATIONS (heart palpitation) and MOBILITY DECREASED (could barely move the arm of injection) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVETIRACETAM (KEPPRA) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), PALPITATIONS (heart palpitation), MOBILITY DECREASED (could barely move the arm of injection), PAIN (aches), CHILLS (chills) and FATIGUE (fatigue). On 26-Mar-2021, the patient experienced COVID-19 (COVID-19). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of UNK dosage form. At the time of the report, COVID-19 (COVID-19), NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), PALPITATIONS (heart palpitation), MOBILITY DECREASED (could barely move the arm of injection), PAIN (aches), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medications were depression medicine and migraine medicine. Other treatment medications taken were  inhaler and a medicine for cough.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Nausea, Rash
Clinical narrative: vertigo spells; over all "crappy feeling"; dizziness; nauseous; headache; rash all over face and chest; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo spells), FEELING ABNORMAL (over all "crappy feeling"), DIZZINESS (dizziness), RASH (rash all over face and chest) and NAUSEA (nauseous) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced RASH (rash all over face and chest). On 22-Mar-2021, the patient experienced VERTIGO (vertigo spells), FEELING ABNORMAL (over all "crappy feeling"), DIZZINESS (dizziness), NAUSEA (nauseous) and HEADACHE (headache). On 20-Mar-2021, RASH (rash all over face and chest) had resolved. At the time of the report, VERTIGO (vertigo spells), FEELING ABNORMAL (over all "crappy feeling"), DIZZINESS (dizziness), NAUSEA (nauseous) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo spells; over all "crappy feeling"; dizziness; nauseous; headache; rash all over face and chest; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo spells), FEELING ABNORMAL (over all "crappy feeling"), DIZZINESS (dizziness), RASH (rash all over face and chest) and NAUSEA (nauseous) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced RASH (rash all over face and chest). On 22-Mar-2021, the patient experienced VERTIGO (vertigo spells), FEELING ABNORMAL (over all "crappy feeling"), DIZZINESS (dizziness), NAUSEA (nauseous) and HEADACHE (headache). On 20-Mar-2021, RASH (rash all over face and chest) had resolved. At the time of the report, VERTIGO (vertigo spells), FEELING ABNORMAL (over all "crappy feeling"), DIZZINESS (dizziness), NAUSEA (nauseous) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with VALACYCLOVIR [VALACICLOVIR] on 29-Mar-2021 for Shingles, at a dose of UNK dosage form. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dizziness, Headache, Myalgia, Oropharyngeal pain
Clinical narrative: Cough; Sore throat; Phlegm; Dizziness; Fever; Headache; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), PRODUCTIVE COUGH (Phlegm), DIZZINESS (Dizziness) and PYREXIA (Fever) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), PRODUCTIVE COUGH (Phlegm), DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle pain). At the time of the report, COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), PRODUCTIVE COUGH (Phlegm), DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough, Pyrexia
Clinical narrative: Cough; Sore throat; Phlegm; Dizziness; Fever; Headache; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), PRODUCTIVE COUGH (Phlegm), DIZZINESS (Dizziness) and PYREXIA (Fever) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), PRODUCTIVE COUGH (Phlegm), DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle pain). At the time of the report, COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat), PRODUCTIVE COUGH (Phlegm), DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous
Clinical narrative: Itching; Red rash in upper body; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching) and RASH ERYTHEMATOUS (Red rash in upper body) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3001176) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PRURITUS (Itching) and RASH ERYTHEMATOUS (Red rash in upper body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form. At the time of the report, PRURITUS (Itching) and RASH ERYTHEMATOUS (Red rash in upper body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: Stiffness left side of body from the tip of head to feet, also stiffness in  neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness left side of body from the tip of head to feet, also stiffness in  neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     The patient's past medical history included No adverse event (No medical history reported.).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness left side of body from the tip of head to feet, also stiffness in  neck). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness left side of body from the tip of head to feet, also stiffness in  neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication was not provided.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: I became dizzy and I am still experiencing it.; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I became dizzy and I am still experiencing it.) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced DIZZINESS (I became dizzy and I am still experiencing it.). At the time of the report, DIZZINESS (I became dizzy and I am still experiencing it.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Vaccination site pain
Clinical narrative: Itchy; Red; Rash; Arm was sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), ERYTHEMA (Red), RASH (Rash) and VACCINATION SITE PAIN (Arm was sore at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore at the injection site). On 30-Mar-2021, the patient experienced PRURITUS (Itchy), ERYTHEMA (Red) and RASH (Rash). The patient was treated with CORTISONE at a dose of Cortisone-10 cream and ALCOHOL at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchy), ERYTHEMA (Red), RASH (Rash) and VACCINATION SITE PAIN (Arm was sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Eczema, Product administered to patient of inappropriate age
Clinical narrative: 16-year-old child was incorrectly given the moderna vaccine; Eczema has flared; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old child was incorrectly given the moderna vaccine) and ECZEMA (Eczema has flared) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-May-2021, the patient experienced ECZEMA (Eczema has flared). On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old child was incorrectly given the moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old child was incorrectly given the moderna vaccine) had resolved and ECZEMA (Eczema has flared) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Follow-up information received on 09-Apr-2021 included batch number of vaccine and contact information of reporter updated. On 25-May-2021: Follow-up information received on 25-May-2021 included second dose details, new event added and action taken with suspect updated.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Nausea, Vaccination site pain, Vaccination site pruritus
Clinical narrative: started itching; 3" X 1" rash over the injection site; still feels sore; exhausted, and stayed in bed; started feeling nauseous; vomiting; feeling weird; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling weird), VACCINATION SITE PRURITUS (started itching), NAUSEA (started feeling nauseous), VOMITING (vomiting) and VACCINATION SITE RASH (3" X 1" rash over the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced FEELING ABNORMAL (feeling weird), NAUSEA (started feeling nauseous) and VOMITING (vomiting). On 06-Mar-2021, the patient experienced FATIGUE (exhausted, and stayed in bed). On 07-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (started itching), VACCINATION SITE RASH (3" X 1" rash over the injection site) and VACCINATION SITE PAIN (still feels sore). On 05-Mar-2021, NAUSEA (started feeling nauseous) and VOMITING (vomiting) had resolved. On 07-Mar-2021, FATIGUE (exhausted, and stayed in bed) had resolved. At the time of the report, FEELING ABNORMAL (feeling weird), VACCINATION SITE PRURITUS (started itching) and VACCINATION SITE RASH (3" X 1" rash over the injection site) outcome was unknown and VACCINATION SITE PAIN (still feels sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       NO concomitant medication details were provided. No treatment information was provided.